grappa monovarietale
Selected indexed studies
- GRAPPA Treatment Recommendations: 2021 Update. (J Rheumatol, 2022) [PMID:35293339]
- Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. (Nat Rev Rheumatol, 2022) [PMID:35761070]
- Generalized autocalibrating partially parallel acquisitions (GRAPPA). (Magn Reson Med, 2002) [PMID:12111967]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- GRAPPA Treatment Recommendations: 2021 Update. (2022) pubmed
- Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. (2022) pubmed
- Generalized autocalibrating partially parallel acquisitions (GRAPPA). (2002) pubmed
- GRAPPA 2021 Treatment Recommendations for Psoriatic Arthritis. (2023) pubmed
- The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: Similarities and differences. (2023) pubmed
- GRAPPA 2024: Key Project Advances. (2025) pubmed
- Efficacy of risankizumab across GRAPPA domains in psoriatic arthritis: a pooled analysis of patients from the phase 3 KEEPsAKE 1 and 2 studies. (2025) pubmed
- Introducing New GRAPPA Projects. (2024) pubmed
- Arthritis mutilans. (2013) pubmed
- GRAPPA 2020 Research Award Recipients. (2022) pubmed